“Molecular Assemblies is the original leader in enzymatic oligo synthesis, with strong foundational IP. Their team has made ...

Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...

Molecular Assemblies proprietary Fully Enzymatic SynthesisTM technology to enhance mRNA and oligonucleotide manufacturing capabilities within the TriLink BioTechnologies business “Molecular ...

Breakthrough study in Nature Materials reveals DNA nanorafts reshape synthetic cells for controlled membrane dynamics and ...

Collagen, the body's most abundant protein, has long been viewed as a predictable structural component of tissues. However, a ...

Maravai LifeSciences (MRVI) announced its acquisition of intellectual property and relevant assets from Molecular Assemblies, or MAI. The ...

“This is a very exciting, highly rigorous piece of work that gives new insights into this molecular-scale control of self-assembly. This helps the whole field move forward by building our ...

Advance quantum information systems through innovative material design. Develop ultrasensitive biosensors for non-invasive ...

SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...